The burden of cytomegalovirus infection remains high in high‐risk kidney transplant recipients despite six‐month valganciclovir prophylaxis
Open Access
- 1 February 2021
- journal article
- research article
- Published by Wiley in Transplant Infectious Disease
- Vol. 23 (4), e13577
- https://doi.org/10.1111/tid.13577
Abstract
Cytomegalovirus continues to be a concern after transplantation despite prophylaxis regimens. Our aim was to analyse post‐prophylaxis primary cytomegalovirus infections among kidney transplant recipients after 6‐month valganciclovir prophylaxis and to determine the usefulness of surveillance after prophylaxis. Data from all cytomegalovirus D+/R‐ kidney transplant recipients from January 2004 to October 2018 at our center who received 6‐month prophylaxis with valganciclovir were retrospectively analysed (N = 481). Detailed analyses were performed for 136 patients who were monitored every 2‐4 weeks for DNAemia after the discontinuation of prophylaxis. Post‐prophylaxis primary cytomegalovirus infection occurred in 182/481 (38%) patients median 264 days after transplantation (IQR: 226‐367) and median 84 days after the end of prophylaxis (IQR: 46‐187). In 49% patients, cytomegalovirus infection occurred over 3 months after the end of prophylaxis. Cytomegalovirus infection was not associated with lower patient or graft survival and no independent risk factors for infection were found. From patients monitored closely, 71/136 (52%) patients developed post‐prophylaxis primary cytomegalovirus infection. Altogether, 52/136 (38%) patients were diagnosed with probable post‐prophylaxis cytomegalovirus disease and 19/136 (14%) patients had asymptomatic CMV infection. Recurrent infection occurred in 38/71 (39%) patients. The incidence of post‐prophylaxis primary cytomegalovirus infection among D+/R‐ kidney transplant recipients remains high despite 6‐month prophylaxis. Surveillance after prophylaxis was challenging as a considerable portion of the infections occurred late and already symptomatic.Keywords
This publication has 40 references indexed in Scilit:
- Extended Valganciclovir Prophylaxis in D+/R− Kidney Transplant Recipients is Associated With Long-Term Reduction in Cytomegalovirus Disease: Two-Year Results of the IMPACT StudyTransplantation, 2010
- The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High‐Risk Kidney Transplant RecipientsAmerican Journal of Transplantation, 2010
- Effect of Cytomegalovirus Viremia on Subclinical Rejection or Interstitial Fibrosis and Tubular Atrophy in Protocol Biopsy at 3 Months in Renal Allograft Recipients Managed by Preemptive Therapy or Antiviral ProphylaxisTransplantation, 2009
- Delayed-Onset Primary Cytomegalovirus Disease and the Risk of Allograft Failure and Mortality after Kidney TransplantationClinical Infectious Diseases, 2008
- Cytomegalovirus infection in renal transplant recipients is associated with impaired survival irrespective of expected mortality riskClinical Transplantation, 2007
- Persistent cytomegalovirus infection in kidney allografts is associated with inferior graft function and survivalTransplant International, 2006
- 24-Week Oral Ganciclovir Prophylaxis in Kidney Recipients Is Associated with Reduced Symptomatic Cytomegalovirus Disease Compared to a 12-Week CourseTransplantation, 2006
- Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survivalKidney International, 2004
- The Impact of Cytomegalovirus Infection and Disease on Rejection Episodes in Renal Allograft RecipientsAmerican Journal of Transplantation, 2002
- A PROSPECTIVE STUDY OF THE NATURAL COURSE OF CYTOMEGALOVIRUS INFECTION AND DISEASE IN RENAL ALLOGRAFT RECIPIENTS1Transplantation, 2000